Epcoritamab
Modify Date: 2024-04-06 18:00:35
Epcoritamab structure
|
Common Name | Epcoritamab | ||
|---|---|---|---|---|
| CAS Number | 2134641-34-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EpcoritamabEpcoritamab (GEN3013) is an bispecific IgG1 antibody redirecting T-cells toward CD3×CD20+ tumor cells. Epcoritamab induces potent T-cell-mediated cytotoxicity towards B-cell NHL cell lines[1]. |
| Name | Epcoritamab |
|---|
| Description | Epcoritamab (GEN3013) is an bispecific IgG1 antibody redirecting T-cells toward CD3×CD20+ tumor cells. Epcoritamab induces potent T-cell-mediated cytotoxicity towards B-cell NHL cell lines[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Epcoritamab (30 ng/mL) 在健康供体外周血单核细胞 (PBMC) 存在的情况下诱导有效的细胞毒性[1]。 |
| References |
| No Any Chemical & Physical Properties |